搜尋結果
UBS CEO says job cuts in Switzerland to start in late 2024
Reuters· 1 日前In a call with journalists, Sergio Ermotti said the cuts are not something the bank sees as ...
US FDA approves Neurocrine Biosciences' movement disorder drug
Reuters· 6 日前, opens new tab Ingrezza drug to treat movement disorders associated with Huntington's disease (HD), the company said on ...